{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:31:33Z","timestamp":1761129093695},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.humimm.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,9]],"date-time":"2013-06-09T22:56:38Z","timestamp":1370818598000},"page":"1288-1294","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma"],"prefix":"10.1016","volume":"74","author":[{"given":"Roberto","family":"Littera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Tondolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Fantola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luchino","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisella","family":"Cappai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Mulargia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Caocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Arras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Floris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"La Nasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Carcassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2013.05.007_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(98)80173-6","article-title":"Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients","volume":"29","author":"Pol","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humimm.2013.05.007_b0015","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1440-1746.2011.06785.x","article-title":"Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C","volume":"26","author":"Walter","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humimm.2013.05.007_b0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2013.05.007_b0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2011.01.005","article-title":"NK cells in acute hepatitis C","volume":"55","author":"Nattermann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.genom.7.080505.115726","article-title":"The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense","volume":"7","author":"Bashirova","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.humimm.2013.05.007_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1074-7613(00)80336-2","article-title":"The binding site of NK receptors on HLA-C molecules","volume":"6","author":"Mandelboim","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2013.05.007_b0045","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.4049\/jimmunol.180.6.3969","article-title":"Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3","volume":"180","author":"Moesta","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.05.007_b0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humimm.2013.05.007_b0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-4-44","article-title":"Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population","volume":"4","author":"Bontadini","year":"2006","journal-title":"J Transl Med"},{"key":"10.1016\/j.humimm.2013.05.007_b0060","unstructured":"http:\/\/www.ebi.ac.uk.\/ipd\/kir\/ IPD KIR Database, last visited on 24 april 2013."},{"key":"10.1016\/j.humimm.2013.05.007_b0065","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.humimm.2013.05.007_b0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JVI.01285-09","article-title":"Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection","volume":"84","author":"Vidal-Casti\u00f1eira","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2013.05.007_b0075","first-page":"1017","article-title":"Distinct KIR\/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses","volume":"118","author":"Ahlenstiel","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2013.05.007_b0080","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humimm.2011.08.017","article-title":"KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C","volume":"72","author":"Marangon","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2013.05.007_b0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/430351","article-title":"Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"192","author":"L\u00f3pez-V\u00e1zquez","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humimm.2013.05.007_b0090","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/jhep.2000.19362","article-title":"Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma","volume":"32","author":"Kawarabayashi","year":"2000","journal-title":"Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0095","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced liver disease study group. The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatol"},{"key":"10.1016\/j.humimm.2013.05.007_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","article-title":"Relevance of KIR gene polymorphisms in bone marrow transplantation outcome","volume":"63","author":"Gagne","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2013.05.007_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2567.2009.03208.x","article-title":"The extensive polymorphism of KIR genes","volume":"129","author":"Middleton","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2013.05.007_b0115","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","article-title":"KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential","volume":"168","author":"Faure","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2013.05.007_b0120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2013.05.007_b0125","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2003-02-0438","article-title":"The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia","volume":"103","author":"Cook","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2013.05.007_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"90","author":"Hsu","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humimm.2013.05.007_b0135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1703271","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humimm.2013.05.007_b0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.exphem.2010.02.012","article-title":"Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients","volume":"38","author":"Caocci","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humimm.2013.05.007_b0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00251-002-0463-7","article-title":"Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes","volume":"54","author":"Uhrberg","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2013.05.007_b0150","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1089\/jir.2006.26.854","article-title":"Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons","volume":"26","author":"Larkin","year":"2006","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"10.1016\/j.humimm.2013.05.007_b0155","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.ppat.0020079","article-title":"KIR\/HLA pleiotropism: protection against both HIV and opportunistic infections","volume":"2","author":"Qi","year":"2006","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.humimm.2013.05.007_b0160","doi-asserted-by":"crossref","first-page":"e25682","DOI":"10.1371\/journal.pone.0025682","article-title":"KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2013.05.007_b0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10552-012-9895-z","article-title":"Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study","volume":"23","author":"Ha","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.humimm.2013.05.007_b0170","first-page":"326","article-title":"Distribution pattern of HCV genotypes & its association with viral load","volume":"133","author":"Chakravarti","year":"2011","journal-title":"Indian J Med Res"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885913001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T21:18:15Z","timestamp":1563139095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885913001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0198885913001481"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2013.05.007","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}